Most recently, targeted RNA interference (RNAi) technology has been used to inhibit anthrax toxin intoxication through silencing ANTXR1 and/or ANTXR2 in mouse and human macrophages [55]. The gene discussed is ANTXR1; the disease is anthrax infection.